SCHEDULE: Vanguard Discloses 5.26% Stake in Ingevity Corp

Vanguard Capital Management has reported beneficial ownership of 5.26% of Ingevity Corp's common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, now beneficially owns 1,853,415 shares of Ingevity Corp common stock.
• This holding represents 5.26% of the total class of securities.
• The filing indicates that Vanguard has sole dispositive power over these shares.
• Vanguard Capital Management LLC, Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd. are involved in this reporting.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of influencing control of Ingevity Corp.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of passive ownership by a large institutional investor and does not contain new operational or financial performance information.

Positives

• Vanguard's significant stake suggests confidence in Ingevity's long-term prospects.
• The reporting is in compliance with SEC regulations, indicating transparency.
• Vanguard has sole dispositive power, allowing for efficient management of the investment.

Negatives

• The filing does not provide specific details on the acquisition cost or strategy behind the investment.
• The exact timing and rationale for reaching the 5.26% threshold are not detailed.

Risks

• Potential for future changes in Vanguard's stake, which could impact Ingevity's stock price.
• If Vanguard decides to sell its stake, it could create downward pressure on the stock.

Future Outlook

The filing does not contain forward-looking statements or guidance from Vanguard regarding future investment in Ingevity Corp.

Management Comments

• "In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd."
• "This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power."
• "This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release."
• "Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that a Schedule 13G filing by a major institutional investor like Vanguard typically signifies a passive investment approach, often indicating a belief in the company's fundamental value and growth potential within the specialty chemicals or materials sector.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's passive stake, which can be viewed positively for stability, but also implies limited direct influence on company strategy by Vanguard.
• Management: The filing is a standard disclosure and does not directly impact management's operational responsibilities, but confirms Vanguard's passive interest.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Vanguard will continue to hold the shares in the ordinary course of business.
• Vanguard will monitor Ingevity Corp's performance and market conditions.

Key Dates

Keywords

Ingevity Corp, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management, Pennsylvania, North Charleston